| Hyperuricemia and cardiovascular disease risk C Borghi, FM Verardi, I Pareo, C Bentivenga, AFG Cicero Expert review of cardiovascular therapy 12 (10), 1219-1225, 2014 | 89 | 2014 |
| Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction ER Cosentino, D Degli Esposti, R Miceli, C Bentivenga, M Landolfo, ... Current Medical Research and Opinion 35 (sup1), 9-12, 2019 | 25 | 2019 |
| Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study ER Cosentino, M Landolfo, C Bentivenga, L Spinardi, DD Esposti, ... BMC cardiovascular disorders 19, 1-7, 2019 | 20 | 2019 |
| Short-term effect of a new oral sodium hyaluronate formulation on knee osteoarthritis: a double-blind, randomized, placebo-controlled clinical trial AFG Cicero, N Girolimetto, C Bentivenga, E Grandi, F Fogacci, C Borghi Diseases 8 (3), 26, 2020 | 9 | 2020 |
| Canrenone on cardiovascular mortality in congestive heart failure: canrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study G Derosa, P Maffioli, L Scelsi, A Bestetti, M Vanasia, AFG Cicero, ... Pharmacological Research 141, 46-52, 2019 | 9 | 2019 |
| Uric acid and risk of myocardial infarction. A dynamic duo C Borghi, C Bentivenga, ER Cosentino International Journal of Cardiology 320, 23-24, 2020 | 8 | 2020 |
| Role of statins on mortality in patients with heart failure ER Cosentino, ER Rinaldi, F Santi, V Immordino, D Degli Esposti, ... High Blood Press Cardiovasc Prev 19, 174, 2012 | 6 | 2012 |
| Coexisting heart failure and chronic obstructive pulmonary disease: report of two cases treated with indacaterol/glycopyrronium ER Cosentino, D Degli Esposti, R Miceli, C Bentivenga, M Landolfo, ... Respiration 95 (Suppl. 1), 3-5, 2018 | 3 | 2018 |
| Iron deficiency correction in heart failure patients with preserved ejection fraction: a case series study ER Cosentino, AFG Cicero, C Bentivenga, M Burchi, C Borghi Archives of Medical Science: AMS 17 (4), 1137, 2021 | 2 | 2021 |
| Management of a multicomorbid patient with heart failure G Magri, C Bentivenga, ER Cosentino, D Degli Esposti, C Borghi, A Dormi Cardiology 138 (Suppl. 1), 21-23, 2017 | 2 | 2017 |
| BLOOD PRESSURE CONTROL, UTERO-PLACENTAL HEMODYNAMIC AND FETAL OUTCOME IN PRE-ECLAMPTIC PATIENTS TREATED WITH NIFEDIPINE-GITS AND METHYLDOPA: P3. 19 C Borghi, V Immordino, A Cassani, C Bentivenga, E Ambrosioni, ... Journal of Hypertension 18, S156, 2000 | 1 | 2000 |
| AB1565 IBD AND LIGAMENTOUS LAXITY ASSOCIATION C Bentivenga, A Varani, NE Politi, ER Cosentino, F Rizzello, C Calabrese, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 2015-2016, 2023 | | 2023 |
| AB0390 OVERACTIVATION OF THE RENIN ANGIOTENSIN SYSTEM AS A POSSIBLE CONTRIBUTOR TO THE INCREASED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS (RA); EVALUATION OF LEUKOCYTE … C Bentivenga, NE Politi, A Bragagni, ER Cosentino, FAG Cicero, M Reta, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1379-1379, 2023 | | 2023 |
| Tailoring treatment to comorbidities C Borghi, C Bentivenga, E Cosentino, M Landolfo Heart and Metabolism, 21, 2019 | | 2019 |
| PREDICTORS OF CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS: CORRELATION BETWEEN THE PRESENCE OF CARDIOVASCULAR DISEASE AND CHARACTERISTICS OF THE JOINT DISEASE C Borghi, C Bentivenga, AF Cicero, M Trevisani, E Rossi, F Viviani, ... Journal of Hypertension 37, e225-e226, 2019 | | 2019 |
| ALLOPURINOL AND FEBUXOSTAT EFFECT ON TOTAL MORTALITY IN HYPERURICEMIC PATIENTS AFFECTED BY MILD-TO-MODERATE HEART FAILURE ER Cosentino, AFG Cicero, D Degli Esposti, C Bentivenga, G Magri, ... Journal of Hypertension 36, e239, 2018 | | 2018 |
| THU0420 Improved survival of post-myocardial infarction patients treated with zofenopril combined with xantine oxidase inhibitors as compared to placebo or other ace-i C Bentivenga, ER Cosentino, F Ventura, G Magri, IR Iamino, S Bacchelli, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 366-366, 2017 | | 2017 |
| Malattia da deposito di urato, normo-iperuricemia e rischio cardiovascolare. C Bentivenga, C Borghi IPERTENSIONE E PREVENZIONE CARDIOVASCOLARE 23 (1), 2-6, 2016 | | 2016 |
| SAT0317 Correlation Between Serum Uric Acid and Left Ventricular Mass in Essential Hypertension ER Rinaldi, C Bentivenga, E Cosentino, S Corvaglia, M Rosticci, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 773-774, 2015 | | 2015 |
| PP. 27.21: CORRELATION BETWEEN SERUM URIC ACID AND LEFT VENTRICULAR MASS IN ESSENTIAL HYPERTENSION E Rinaldi, E Cosentino, C Bentivenga, IR Iamino, M Rosticci, AFG Cicero, ... Journal of Hypertension 33, e371, 2015 | | 2015 |
